(CLFD) Clearfield - Overview
Stock: Fiber Panels, Fiber Cabinets, Fiber Pedestals, Fiber Pathway, Fiber Connectors
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 50.1% |
| Relative Tail Risk | -0.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -35.68 |
| Character TTM | |
|---|---|
| Beta | 1.296 |
| Beta Downside | 1.316 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.59% |
| CAGR/Max DD | -0.32 |
Description: CLFD Clearfield December 26, 2025
Clearfield, Inc. (NASDAQ: CLFD) designs, manufactures, and distributes a portfolio of fiber-management hardware-including the FieldSmart enclosure series, WaveSmart optical-component platforms, and FiberFlex outdoor cabinets-targeting both indoor and outdoor network deployments.
The company’s product suite also covers access-terminal solutions (CraftSmart FiberFirst pedestals, YOURx mid-span terminals), protective pathways (FieldShield), custom fiber assemblies, and connector-cleaning accessories, enabling service providers to deliver fiber-to-the-premise (FTTP), fiber-to-the-business (FTTB), and metro-core/backhaul infrastructure.
Clearfield serves a broad customer base that spans national carriers, community broadband operators, multiple-system operators, large enterprises, and OEMs, selling primarily through a direct sales force and an authorized distributor network. In FY 2023 the company reported $124 million in revenue, a 12 % year-over-year increase driven by rising telecom capex tied to 5G rollout and broadband expansion, and maintained an adjusted EBITDA margin of roughly 14 %.
Key sector dynamics include the U.S. Federal Communications Commission’s broadband-deployment incentives and the accelerating demand for small-cell backhaul, both of which underpin long-term growth for fiber-management equipment providers.
For a deeper quantitative view, you may want to explore ValueRay’s analyst dashboard for CLFD.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -8.05m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.06 > 1.0 |
| NWC/Revenue: 107.8% < 20% (prev 123.1%; Δ -15.29% < -1%) |
| CFO/TA 0.10 > 3% & CFO 29.4m > Net Income -8.05m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.9m) vs 12m ago -2.27% < -2% |
| Gross Margin: 33.66% > 18% (prev 0.17%; Δ 3349 % > 0.5%) |
| Asset Turnover: 48.32% > 50% (prev 52.88%; Δ -4.56% > 0%) |
| Interest Coverage Ratio: 13.09 > 6 (EBITDA TTM -3.96b / Interest Expense TTM 550.0k) |
Altman Z'' 7.05
| A: 0.53 (Total Current Assets 198.5m - Total Current Liabilities 36.6m) / Total Assets 306.2m |
| B: 0.35 (Retained Earnings 106.9m / Total Assets 306.2m) |
| C: 0.02 (EBIT TTM 7.20m / Avg Total Assets 310.7m) |
| D: 2.18 (Book Value of Equity 108.8m / Total Liabilities 50.0m) |
| Altman-Z'' Score: 7.05 = AAA |
Beneish M -3.12
| DSRI: 0.94 (Receivables 18.0m/21.3m, Revenue 150.1m/166.7m) |
| GMI: 0.51 (GM 33.66% / 17.33%) |
| AQI: 2.01 (AQ_t 0.29 / AQ_t-1 0.15) |
| SGI: 0.90 (Revenue 150.1m / 166.7m) |
| TATA: -0.12 (NI -8.05m - CFO 29.4m) / TA 306.2m) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of CLFD shares?
Over the past week, the price has changed by +3.83%, over one month by +0.32%, over three months by -5.62% and over the past year by -16.31%.
Is CLFD a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CLFD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.5 | 40.7% |
| Analysts Target Price | 43.5 | 40.7% |
| ValueRay Target Price | 28.3 | -8.4% |
CLFD Fundamental Data Overview February 02, 2026
P/E Forward = 39.6825
P/S = 2.7457
P/B = 1.6103
Revenue TTM = 150.1m USD
EBIT TTM = 7.20m USD
EBITDA TTM = -3.96b USD
Long Term Debt = 8.76m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.82m USD (from shortTermDebt, last quarter)
Debt = 8.76m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.7m USD (from netDebt column, last quarter)
Enterprise Value = 315.0m USD (412.2m + Debt 8.76m - CCE 106.0m)
Interest Coverage Ratio = 13.09 (Ebit TTM 7.20m / Interest Expense TTM 550.0k)
EV/FCF = 12.75x (Enterprise Value 315.0m / FCF TTM 24.7m)
FCF Yield = 7.84% (FCF TTM 24.7m / Enterprise Value 315.0m)
FCF Margin = 16.46% (FCF TTM 24.7m / Revenue TTM 150.1m)
Net Margin = -5.36% (Net Income TTM -8.05m / Revenue TTM 150.1m)
Gross Margin = 33.66% ((Revenue TTM 150.1m - Cost of Revenue TTM 99.6m) / Revenue TTM)
Gross Margin QoQ = 73.52% (prev 30.53%)
Tobins Q-Ratio = 1.03 (Enterprise Value 315.0m / Total Assets 306.2m)
Interest Expense / Debt = 3.14% (Interest Expense 275.0k / Debt 8.76m)
Taxrate = 15.33% (956.0k / 6.24m)
NOPAT = 6.09m (EBIT 7.20m * (1 - 15.33%))
Current Ratio = 5.42 (Total Current Assets 198.5m / Total Current Liabilities 36.6m)
Debt / Equity = 0.03 (Debt 8.76m / totalStockholderEquity, last quarter 256.2m)
Debt / EBITDA = 0.00 (negative EBITDA) (Net Debt -12.7m / EBITDA -3.96b)
Debt / FCF = -0.52 (Net Debt -12.7m / FCF TTM 24.7m)
Total Stockholder Equity = 263.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.59% (Net Income -8.05m / Total Assets 306.2m)
RoE = -3.06% (Net Income TTM -8.05m / Total Stockholder Equity 263.5m)
RoCE = 2.64% (EBIT 7.20m / Capital Employed (Equity 263.5m + L.T.Debt 8.76m))
RoIC = 2.29% (NOPAT 6.09m / Invested Capital 265.7m)
WACC = 10.52% (E(412.2m)/V(421.0m) * Re(10.69%) + D(8.76m)/V(421.0m) * Rd(3.14%) * (1-Tc(0.15)))
Discount Rate = 10.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.37%
[DCF Debug] Terminal Value 59.78% ; FCFF base≈19.9m ; Y1≈13.1m ; Y5≈5.96m
Fair Price DCF = 6.81 (EV 81.6m - Net Debt -12.7m = Equity 94.3m / Shares 13.8m; r=10.52% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -70.00 | EPS CAGR: -22.11% | SUE: 0.24 | # QB: 0
Revenue Correlation: -65.72 | Revenue CAGR: -24.76% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-09-30): EPS=0.65 | Chg30d=-0.210 | Revisions Net=+0 | Growth EPS=+43.3% | Growth Revenue=+9.7%
EPS next Year (2027-09-30): EPS=1.70 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+163.6% | Growth Revenue=+23.1%